British Columbia Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Buy
16,392
+1,059
+7% +$208K 0.02% 471
2026
Q1
$3M Sell
15,333
-4,447
-22% -$864K 0.02% 491
2025
Q4
$3.43M Buy
19,780
+3,735
+23% +$680K 0.02% 511
2025
Q3
$3.06M Sell
16,045
-1,512
-9% -$268K 0.02% 482
2025
Q2
$3.15M Sell
17,557
-3,786
-18% -$658K 0.02% 477
2025
Q1
$3.61M Buy
21,343
+29
+0.1% +$4.76K 0.02% 473
2024
Q4
$3.22M Buy
21,314
+2,779
+15% +$432K 0.02% 518
2024
Q3
$2.88M Sell
18,535
-2,670
-13% -$399K 0.02% 523
2024
Q2
$2.9M Buy
21,205
+7,781
+58% +$1.07M 0.02% 524
2024
Q1
$1.79M Buy
13,424
+502
+4% +$65.1K 0.01% 594
2023
Q4
$1.78M Buy
12,922
+2,776
+27% +$365K 0.01% 560
2023
Q3
$1.24M Hold
10,146
0.01% 573
2023
Q2
$1.43M Hold
10,146
0.01% 549
2023
Q1
$1.44M Sell
10,146
-185
-2% -$26.5K 0.02% 531
2022
Q4
$1.62M Sell
10,331
-1,246
-11% -$179K 0.02% 496
2022
Q3
$1.42M Sell
11,577
-2,285
-16% -$301K 0.02% 530
2022
Q2
$1.84M Sell
13,862
-5,075
-27% -$692K 0.02% 526
2022
Q1
$2.59M Sell
18,937
-2,500
-12% -$348K 0.02% 586
2021
Q4
$3.71M Sell
21,437
-2,701
-11% -$411K 0.02% 519
2021
Q3
$3.51M Sell
24,138
-540
-2% -$79K 0.02% 541
2021
Q2
$3.26M Buy
24,678
+2,565
+12% +$336K 0.02% 583
2021
Q1
$2.84M Sell
22,113
-526
-2% -$64.8K 0.02% 550
2020
Q4
$2.7M Sell
22,639
-554
-2% -$67.5K 0.02% 553
2020
Q3
$2.65M Buy
23,193
+1,808
+8% +$214K 0.02% 506
2020
Q2
$2.44M Buy
21,385
+6,650
+45% +$705K 0.02% 484
2020
Q1
$1.18M Sell
14,735
-16,999
-54% -$1.76M 0.02% 508
2019
Q4
$3.39M Buy
31,734
+898
+3% +$93.6K 0.03% 483
2019
Q3
$3.3M Sell
30,836
-19,151
-38% -$1.97M 0.03% 447
2019
Q2
$5.09M Buy
49,987
+10,883
+28% +$1.05M 0.04% 433
2019
Q1
$3.52M Sell
39,104
-38,505
-50% -$3.34M 0.03% 520
2018
Q4
$6.46M Buy
77,609
+35,773
+86% +$3.35M 0.06% 339
2018
Q3
$4.51M Sell
41,836
-15,452
-27% -$1.69M 0.05% 419
2018
Q2
$6.3M Sell
57,288
-15,824
-22% -$1.65M 0.06% 398
2018
Q1
$7.33M Sell
73,112
-4,545
-6% -$465K 0.06% 396
2017
Q4
$7.65M Buy
77,657
+482
+0.6% +$45.7K 0.05% 397
2017
Q3
$7.23M Buy
77,175
+6,000
+8% +$637K 0.06% 380
2017
Q2
$7.91M Sell
71,175
-77,778
-52% -$8.22M 0.06% 367
2017
Q1
$14.6M Buy
148,953
+77,923
+110% +$7.43M 0.12% 216
2016
Q4
$6.53M Buy
71,030
+6,571
+10% +$566K 0.06% 382
2016
Q3
$5.46M Sell
64,459
-29,104
-31% -$2.44M 0.06% 395
2016
Q2
$7.62M Buy
93,563
+48,776
+109% +$3.71M 0.07% 331
2016
Q1
$3.2M Buy
44,787
+1,200
+3% +$80.5K 0.03% 551
2015
Q4
$3.1M Buy
43,587
+16,492
+61% +$1.11M 0.03% 560
2015
Q3
$1.67M Sell
27,095
-4,000
-13% -$280K 0.02% 572
2015
Q2
$2.25M Buy
31,095
+5,783
+23% +$427K 0.02% 545
2015
Q1
$1.95M Sell
25,312
-15,130
-37% -$1.08M 0.02% 573
2014
Q4
$2.71M Sell
40,442
-57,280
-59% -$3.61M 0.02% 519
2014
Q3
$5.93M Sell
97,722
-23,586
-19% -$1.45M 0.05% 383
2014
Q2
$7.12M Sell
121,308
-10,954
-8% -$641K 0.06% 360
2014
Q1
$7.66M Sell
132,262
-25,209
-16% -$1.35M 0.06% 337
2013
Q4
$8.43M Buy
157,471
+4,318
+3% +$256K 0.07% 324
2013
Q3
$9.46M Buy
153,153
+21,251
+16% +$1.27M 0.08% 289
2013
Q2
$8M Buy
+131,902
New +$7.86M 0.07% 335

Other funds holding DGX

British Columbia Investment Management's DGX Position: Q2 2026 in Review

British Columbia Investment Management increased its Quest Diagnostics (DGX) stake by 6.9% in Q2 2026, buying an estimated $208K and bringing the position to 16,392 shares worth $3.47M. The position accounts for 0.02% of the portfolio, ranked #471.

British Columbia Investment Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.6M in Q1 2017. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • British Columbia Investment Management held 16,392 shares of Quest Diagnostics worth $3.47M as of Q2 2026.
  • British Columbia Investment Management bought 1,059 Quest Diagnostics shares in Q2 2026, an estimated $208K.
  • Quest Diagnostics made up 0.02% of British Columbia Investment Management's portfolio in Q2 2026, its #471 holding.
  • British Columbia Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • British Columbia Investment Management's Quest Diagnostics position peaked at $14.6M in Q1 2017.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on British Columbia Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.